Spatiotemporal prevalence of COVID-19 and SARS-CoV-2 variants in Africa

Li-Ping Gao1, Can-Jun Zheng2, Ting-Ting Tian1

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

PubMed

Insights

This study analyzes COVID-19's spread and SARS-CoV-2 variants in Africa from 2020-2023. Higher health spending correlated with increased case incidence, highlighting the need for stronger health systems.

Area of Science:

  • Epidemiology
  • Virology
  • Public Health

Background:

  • The COVID-19 pandemic significantly impacted Africa, yet patterns of disease spread and SARS-CoV-2 variant circulation remain under-documented.
  • Understanding these dynamics is crucial for effective public health responses and preparedness.

Purpose of the Study:

  • To comprehensively analyze the epidemiological patterns and circulating SARS-CoV-2 variants across Africa.
  • To investigate the relationship between national health indexes and COVID-19 case incidences.

Main Methods:

  • Analysis of national data on COVID-19 cases, incidence, mortality, and SARS-CoV-2 variant circulation from January 2020 to December 2023.
  • Utilized SaTScan for spatiotemporal cluster detection and Geographically Weighted Regression (GWR) to assess correlations with health indexes.

Main Results:

  • Identified four major COVID-19 waves, each linked to specific SARS-CoV-2 variants (Alpha, Beta, Eta, Delta, Omicron).
  • Detected 12 distinct variants of concern (VOCs) and interest (VOIs), with Omicron and Delta being most prevalent in later waves.
  • Observed higher COVID-19 incidence and mortality in Southern and Northern Africa; higher health expenditure and personnel indexes correlated with increased reported case incidences.

Conclusions:

  • Africa experienced distinct COVID-19 waves driven by emerging SARS-CoV-2 variants, with regional variations in variant prevalence and disease burden.
  • Strengthening health institutions is vital for early detection of new variants and future pandemic preparedness.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.8K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
292
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K